These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21210170)

  • 41. Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells.
    Yamaguchi M; Vikulina T; Weitzmann MN
    Oncol Rep; 2015 Oct; 34(4):2156-62. PubMed ID: 26260090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formation of mucous membrane lesions secondary to prolonged use of one per cent aqueous gentian violet.
    SLOTKOWSKI EL
    J Pediatr; 1957 Dec; 51(6):652-4. PubMed ID: 13481803
    [No Abstract]   [Full Text] [Related]  

  • 43. Incidence of oral thrush in newborn-infants during 1960 to 1962 at Sassoon Hospitals, Poona, and a comparative evaluation of treatment with some antifungal agents.
    Padhye AA; Thirumalachar MJ; Anjaneyulu R
    Hindustan Antibiot Bull; 1967 Feb; 9(3):143-51. PubMed ID: 6044459
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of gentian violet on virulent properties of Candida albicans.
    Ying S; Qing S; Chunyang L
    Mycopathologia; 2010 Apr; 169(4):279-85. PubMed ID: 19937129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Responsiveness of nonHerlitz junctional epidermolysis bullosa to topical gentian violet.
    Venugopal SS; Intong LR; Cohn HI; Mather-Hillon J; Murrell DF
    Int J Dermatol; 2010 Nov; 49(11):1282-5. PubMed ID: 20964648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of lawsone methyl ether mouthwash on oral Candida in HIV-infected subjects and subjects with denture stomatitis.
    Nittayananta W; Pangsomboon K; Panichayupakaranant P; Chanowanna N; Chelae S; Vuddhakul V; Sukhumungoon P; Pruphetkaew N
    J Oral Pathol Med; 2013 Oct; 42(9):698-704. PubMed ID: 23586936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucosal irritation following use of gentian violet.
    Slotkowski EL; Redondo D
    Am J Dis Child; 1966 Jul; 112(1):40-2. PubMed ID: 4951362
    [No Abstract]   [Full Text] [Related]  

  • 49. Review of the use of gentian violet in dermatology practice.
    Pona A; Quan EY; Cline A; Feldman SR
    Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light.
    Ramirez LE; Lages-Silva E; Pianetti GM; Rabelo RM; Bordin JO; Moraes-Souza H
    Transfusion; 1995 Mar; 35(3):226-30. PubMed ID: 7878715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].
    Castillo-Martínez NA; Mouriño-Pérez RR; Cornejo-Bravo JM; Gaitán-Cepeda LA
    Rev Chilena Infectol; 2018 Aug; 35(4):377-385. PubMed ID: 30534924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of gentian violet on the elimination of methicillin-resistant Staphylococcus aureus (MRSA) existing in the decubitus region].
    Saji M; Taguchi S; Hayama N; Ohzono E; Kobayashi Y; Uchiyama K; Kanekawa T; Ohkuni H
    Nihon Ronen Igakkai Zasshi; 1993 Sep; 30(9):795-801. PubMed ID: 8230793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RCT on gentian violet versus a hydrogel dressing for radiotherapy-induced moist skin desquamation.
    Gollins S; Gaffney C; Slade S; Swindell R
    J Wound Care; 2008 Jun; 17(6):268-70, 272, 274-5. PubMed ID: 18666721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of the feasibility of the use of gentian violet as a fungistat for poultry feed.
    Kingsland GC; Anderson J
    Poult Sci; 1976 May; 55(3):852-7. PubMed ID: 819918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.
    Vazquez JA
    Pharmacotherapy; 1999 Jan; 19(1):76-87. PubMed ID: 9917080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gentian violet 1% solution in the treatment of wounds in the geriatric patient: a retrospective study.
    Farid KJ; Kelly K; Roshin S
    Geriatr Nurs; 2011; 32(2):85-95. PubMed ID: 21324408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosing and managing oral candidiasis.
    Allen CM
    J Am Dent Assoc; 1992 Jan; 123(1):77-8, 81-2. PubMed ID: 1740577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions.
    Lilly EA; Shetty KV; Leigh JE; Cheeks C; Fidel PL
    Med Mycol; 2005 Sep; 43(6):517-23. PubMed ID: 16323309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ototoxicity of gentian violet on the guinea pig cochlea.
    Higuchi H; Yamano T; Takase H; Yoshimura H; Nakagawa T; Morizono T
    Otol Neurotol; 2014 Apr; 35(4):743-7. PubMed ID: 24622028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.